Healthmap Solutions Secures $100 Million in Series B Funding to Revolutionize Kidney Population Health Management

Healthmap Solutions, a renowned NCQA-accredited leader in kidney population health management, has successfully raised an impressive $100 million in its latest funding round. This strategic investment emphasizes the company’s commitment to harnessing advanced technology and big data resources to enhance the lives of individuals living with kidney disease. With a mission to champion better health for vulnerable populations, Healthmap Solutions goes beyond merely providing care; they implement integrated clinical expertise and complex care management that assists healthcare providers and payers in achieving essential value-based outcomes. The funding will be pivotal in expanding Healthmap's innovative platforms and tools, allowing the company to better serve a growing patient population while supporting healthcare partners in their quest for improved health results. As a diverse and expanding organization, this funding will bolster Healthmap's capacity to address the unique needs of its clients and employees alike, driving collaborative efforts to ensure that those who require kidney care receive the best possible support. The infusion of capital signifies not only an endorsement of Healthmap’s impactful work but also a catalyst for future growth and success in revolutionizing kidney healthcare. As Healthmap Solutions continues to forge ahead, this funding positions the company to further its mission: creating a healthier future for the millions affected by kidney issues and reinforcing its status as a champion for better health within the communities it serves.